Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
20.97
-0.21 (-0.99%)
At close: Dec 5, 2025, 4:00 PM EST
20.80
-0.17 (-0.81%)
After-hours: Dec 5, 2025, 7:43 PM EST
Roivant Sciences Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Roivant Sciences stock have an average target of 21.19, with a low estimate of 16.5 and a high estimate of 26. The average target predicts an increase of 1.05% from the current stock price of 20.97.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Roivant Sciences stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 3 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 9 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $25 → $26 | Strong Buy | Maintains | $25 → $26 | +23.99% | Nov 11, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $16 → $25 | Strong Buy | Maintains | $16 → $25 | +19.22% | Oct 29, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $20 → $24 | Strong Buy | Maintains | $20 → $24 | +14.45% | Sep 18, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | -4.63% | Sep 18, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $16 → $20 | Buy | Maintains | $16 → $20 | -4.63% | Sep 18, 2025 |
Financial Forecast
Revenue This Year
20.45M
from 29.05M
Decreased by -29.60%
Revenue Next Year
97.54M
from 20.45M
Increased by 376.94%
EPS This Year
-1.27
from -0.24
EPS Next Year
-1.47
from -1.27
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 35.7M | 256.4M | |||
| Avg | 20.5M | 97.5M | |||
| Low | 8.8M | 18.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 22.9% | 1,153.9% | |||
| Avg | -29.6% | 376.9% | |||
| Low | -69.6% | -11.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.90 | -0.92 | |||
| Avg | -1.27 | -1.47 | |||
| Low | -1.78 | -1.92 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.